ABCL vs AMD · rev $28.8M vs P/E 157, rev $11.54B
Abcellera Biologics Inc (ABCL) versus Advanced Micro Devices Inc (AMD) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
ABCL currently screens at market cap $1.12B. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Not investment advice. Open the ABCL and AMD stock pages for the full models.
Not investment advice.